Data for "Life course malaria exposure and SARS-CoV-2 Sero-epidemiology in Ugandan adolescents: a longitudinal study nested in a birth cohort" – User Guide

Persistent identifier

10.17037/DATA.00005044

Description

This data was collected from a longitudinal study nested within the Entebbe Mother and Baby Study birth cohort in Uganda. Adolescents were enrolled and followed up 6 and 12 months later. Blood samples were collected at each visit for SARS-CoV-2 serology. Malaria exposure was defined using prospectively collected data on clinical malaria (from birth to 10 years), asymptomatic parasitaemia at annual visits, and antibody responses to Plasmodium falciparum merozoite surface protein 2 (PfMSP-2) and apical membrane antigen 1 (PfAMA-1). The primary outcome was SARS-CoV-2 seropositivity, based on spike and nucleocapsid IgG responses, with seropositivity cut-offs derived from pre-pandemic samples. Secondary outcomes, including antibody concentrations and symptomatic PCR-confirmed disease, were explored.

Data collection methods

Field observation - participant

Geographic regions

Uganda

Key dates

• Data collection period: 30 April 2011 - 31 December 2022

Population

Adolescents enrolled in the Entebbe Mother and Baby Study birth cohort.

Privacy

Study data de-identified prior to submission.

Ethics

Keywords

Malaria, SARS-CoV-2, Longitudinal, Uganda

Language of written material

English

Project information

Creators

File description